Finally, we conducted external validation using The Cancer Genome Atlas (TCGA) database and further performed functional assays and drug sensitivity analyses on ATOH8 and DNASE2, additional tumor-specific markers identified by MR analysis. This evidence concerns the gene ATOH8 and neoplasm.